117 related articles for article (PubMed ID: 7306924)
1. Plasma prolactin levels in patients with breast cancer.
Rose DP; Pruitt BT
Cancer; 1981 Dec; 48(12):2687-91. PubMed ID: 7306924
[TBL] [Abstract][Full Text] [Related]
2. Plasma prolactin as an indicator of disease progression in advanced breast cancer.
Bhatavdekar JM; Shah NG; Balar DB; Patel DD; Bhaduri A; Trivedi SN; Karelia NH; Ghosh N; Shukla MK; Giri DD
Cancer; 1990 May; 65(9):2028-32. PubMed ID: 2372769
[TBL] [Abstract][Full Text] [Related]
3. Relation between tumour size and plasma prolactin levels in premenopausal patients with breast carcinoma. A preliminary report.
Olsson H; Ewers SB; Landin-Olsson M; Ranstam J
Acta Radiol Oncol; 1985; 24(1):57-9. PubMed ID: 2984903
[TBL] [Abstract][Full Text] [Related]
4. Circulating levels of testosterone, 17 beta-oestradiol, luteinising hormone and prolactin in postmenopausal breast cancer patients.
Secreto G; Recchione C; Cavalleri A; Miraglia M; Dati V
Br J Cancer; 1983 Feb; 47(2):269-75. PubMed ID: 6824571
[TBL] [Abstract][Full Text] [Related]
5. Plasma lipids and prolactin in patients with breast cancer.
Bani IA; Williams CM; Boulter PS; Dickerson JW
Br J Cancer; 1986 Sep; 54(3):439-46. PubMed ID: 3756079
[TBL] [Abstract][Full Text] [Related]
6. Relationship between plasma progesterone, estradiol and prolactin concentrations and breast cancer in pre and postmenopausal women.
Raheem SN; Atoum M; Al-Hourani H; Rasheed M; Nimer N; Almuhrib T
Neoplasma; 2010; 57(1):74-8. PubMed ID: 19895176
[TBL] [Abstract][Full Text] [Related]
7. A prospective study of plasma prolactin levels and subsequent risk of breast cancer.
Kwa HG; Cleton F; Wang DY; Bulbrook RD; Bulstrode JC; Hayward JL; Millis RR; Cuzick J
Int J Cancer; 1981 Dec; 28(6):673-6. PubMed ID: 7333701
[TBL] [Abstract][Full Text] [Related]
8. Prolactin concentrations in patients with breast cancer.
Franks S; Ralphs DN; Seagroatt V; Jacobs HS
Br Med J; 1974 Nov; 4(5940):320-1. PubMed ID: 4434088
[TBL] [Abstract][Full Text] [Related]
9. Serum prolactin levels in women with breast cancer and their relationship to survival.
Wang DY; Hampson S; Kwa HG; Moore JW; Bulbrook RD; Fentiman IS; Hayward JL; King RJ; Millis RR; Rubens RD
Eur J Cancer Clin Oncol; 1986 Apr; 22(4):487-92. PubMed ID: 3732352
[TBL] [Abstract][Full Text] [Related]
10. Disordered nocturnal prolactin regulation in women with breast cancer.
Malarkey WB; Schroeder LL; Stevens VC; James AG; Lanese RR
Cancer Res; 1977 Dec; 37(12):4650-4. PubMed ID: 922745
[TBL] [Abstract][Full Text] [Related]
11. A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer.
Tworoger SS; Eliassen AH; Sluss P; Hankinson SE
J Clin Oncol; 2007 Apr; 25(12):1482-8. PubMed ID: 17372279
[TBL] [Abstract][Full Text] [Related]
12. [Plasma-prolactin concentrations in breast cancer at various stages, in mastopathy and other malignant tumors].
Holtkamp W; von Heyden D; Rauschecker H; Nagel GA
Schweiz Med Wochenschr; 1983 Oct; 113(41):1513-20. PubMed ID: 6635641
[TBL] [Abstract][Full Text] [Related]
13. Plasma prolactin levels in women at postmenopausal age with a family history of breast cancer or a prescription for antihypertensive Rauwolfia treatment.
de Waard F; Kwa HG; Poortman J
Oncology; 1980; 37(1):33-6. PubMed ID: 7350553
[TBL] [Abstract][Full Text] [Related]
14. [Changes in prolactin plasma levels in relation to menopausal status in primary breast carcinoma].
Pavić S; Pavić Z
Med Pregl; 1995; 48(5-6):159-61. PubMed ID: 7565335
[TBL] [Abstract][Full Text] [Related]
15. Reproductive factors and family history of breast cancer in relation to plasma prolactin levels in premenopausal and postmenopausal women.
Eliassen AH; Tworoger SS; Hankinson SE
Int J Cancer; 2007 Apr; 120(7):1536-41. PubMed ID: 17211859
[TBL] [Abstract][Full Text] [Related]
16. Serum prolactin levels and their relationship to survival in women with operable breast cancer.
Wang DY; Stepniewska KA; Allen DS; Fentiman IS; Bulbrook RD; Kwa HG; De Stavola BL; Reed MJ
J Clin Epidemiol; 1995 Jul; 48(7):959-68. PubMed ID: 7782804
[TBL] [Abstract][Full Text] [Related]
17. Circulating hormone concentrations in women with breast cancer.
McFadyen IJ; Forrest AP; Prescott RJ; Golder MP; Groom GV; Fahmy DR; Griffiths K
Lancet; 1976 May; 1(7969):1100-2. PubMed ID: 57508
[TBL] [Abstract][Full Text] [Related]
18. Paradoxical effects associated with supranormal urinary testosterone excretion in premenopausal women with breast cancer: increased risk of postmastectomy recurrence and higher remission rate after ovariectomy.
Secreto G; Zumoff B
Cancer Res; 1983 Jul; 43(7):3408-11. PubMed ID: 6850646
[TBL] [Abstract][Full Text] [Related]
19. Prolactin and breast skin temperature rhythms in postmenopausal women with primary breast cancer.
Wilson DW; Phillips MJ; Holliday HW; Blamey RW; Simpson HW; Pierrepoint CG; Halberg F; Griffiths K
Chronobiologia; 1983; 10(1):21-30. PubMed ID: 6851763
[TBL] [Abstract][Full Text] [Related]
20. Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women.
Tworoger SS; Sluss P; Hankinson SE
Cancer Res; 2006 Feb; 66(4):2476-82. PubMed ID: 16489055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
